217 related articles for article (PubMed ID: 9293811)
1. Changes in cerebral blood flow and oxygen metabolism related to magnetic resonance imaging white matter hyperintensities in Alzheimer's disease.
Yamaji S; Ishii K; Sasaki M; Imamura T; Kitagaki H; Sakamoto S; Mori E
J Nucl Med; 1997 Sep; 38(9):1471-4. PubMed ID: 9293811
[TBL] [Abstract][Full Text] [Related]
2. Decreased medial temporal oxygen metabolism in Alzheimer's disease shown by PET.
Ishii K; Kitagaki H; Kono M; Mori E
J Nucl Med; 1996 Jul; 37(7):1159-65. PubMed ID: 8965188
[TBL] [Abstract][Full Text] [Related]
3. Cerebral blood flow and oxygen metabolism in senile dementia of Alzheimer's type and vascular dementia with deep white matter changes.
Tohgi H; Yonezawa H; Takahashi S; Sato N; Kato E; Kudo M; Hatano K; Sasaki T
Neuroradiology; 1998 Mar; 40(3):131-7. PubMed ID: 9561514
[TBL] [Abstract][Full Text] [Related]
4. Regional difference in cerebral blood flow and oxidative metabolism in human cortex.
Ishii K; Sasaki M; Kitagaki H; Sakamoto S; Yamaji S; Maeda K
J Nucl Med; 1996 Jul; 37(7):1086-8. PubMed ID: 8965174
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of whole-brain oxygen metabolism in Alzheimer's disease using QSM and quantitative BOLD.
Yang A; Zhuang H; Du L; Liu B; Lv K; Luan J; Hu P; Chen F; Wu K; Shu N; Shmuel A; Ma G; Wang Y
Neuroimage; 2023 Nov; 282():120381. PubMed ID: 37734476
[TBL] [Abstract][Full Text] [Related]
6. Application of calibrated fMRI in Alzheimer's disease.
Lajoie I; Nugent S; Debacker C; Dyson K; Tancredi FB; Badhwar A; Belleville S; Deschaintre Y; Bellec P; Doyon J; Bocti C; Gauthier S; Arnold D; Kergoat MJ; Chertkow H; Monchi O; Hoge RD
Neuroimage Clin; 2017; 15():348-358. PubMed ID: 28560160
[TBL] [Abstract][Full Text] [Related]
7. White matter hyperintensities and imaging patterns of brain ageing in the general population.
Habes M; Erus G; Toledo JB; Zhang T; Bryan N; Launer LJ; Rosseel Y; Janowitz D; Doshi J; Van der Auwera S; von Sarnowski B; Hegenscheid K; Hosten N; Homuth G; Völzke H; Schminke U; Hoffmann W; Grabe HJ; Davatzikos C
Brain; 2016 Apr; 139(Pt 4):1164-79. PubMed ID: 26912649
[TBL] [Abstract][Full Text] [Related]
8. Increased cortical capillary transit time heterogeneity in Alzheimer's disease: a DSC-MRI perfusion study.
Eskildsen SF; Gyldensted L; Nagenthiraja K; Nielsen RB; Hansen MB; Dalby RB; Frandsen J; Rodell A; Gyldensted C; Jespersen SN; Lund TE; Mouridsen K; Brændgaard H; Østergaard L
Neurobiol Aging; 2017 Feb; 50():107-118. PubMed ID: 27951412
[TBL] [Abstract][Full Text] [Related]
9. Misery perfusion with preserved vascular reactivity in Alzheimer's disease.
Nagata K; Buchan RJ; Yokoyama E; Kondoh Y; Sato M; Terashi H; Satoh Y; Watahiki Y; Senova M; Hirata Y; Hatazawa J
Ann N Y Acad Sci; 1997 Sep; 826():272-81. PubMed ID: 9329699
[TBL] [Abstract][Full Text] [Related]
10. Decline in total cerebral blood flow is linked with increase in periventricular but not deep white matter hyperintensities.
ten Dam VH; van den Heuvel DM; de Craen AJ; Bollen EL; Murray HM; Westendorp RG; Blauw GJ; van Buchem MA
Radiology; 2007 Apr; 243(1):198-203. PubMed ID: 17329688
[TBL] [Abstract][Full Text] [Related]
11. Neuropathological basis of magnetic resonance images in aging and dementia.
Jagust WJ; Zheng L; Harvey DJ; Mack WJ; Vinters HV; Weiner MW; Ellis WG; Zarow C; Mungas D; Reed BR; Kramer JH; Schuff N; DeCarli C; Chui HC
Ann Neurol; 2008 Jan; 63(1):72-80. PubMed ID: 18157909
[TBL] [Abstract][Full Text] [Related]
12. Relationship between white matter lesions and regional cerebral blood flow changes during longitudinal follow up in Alzheimer's disease.
Hanaoka T; Kimura N; Aso Y; Takemaru M; Kimura Y; Ishibashi M; Matsubara E
Geriatr Gerontol Int; 2016 Jul; 16(7):836-42. PubMed ID: 26245516
[TBL] [Abstract][Full Text] [Related]
13. Comparison of CT, MR, and PET in Alzheimer's dementia and normal aging.
Fazekas F; Alavi A; Chawluk JB; Zimmerman RA; Hackney D; Bilaniuk L; Rosen M; Alves WM; Hurtig HI; Jamieson DG
J Nucl Med; 1989 Oct; 30(10):1607-15. PubMed ID: 2795200
[TBL] [Abstract][Full Text] [Related]
14. Brain volume and white matter hyperintensities as determinants of cerebral blood flow in Alzheimer's disease.
Benedictus MR; Binnewijzend MAA; Kuijer JPA; Steenwijk MD; Versteeg A; Vrenken H; Scheltens P; Barkhof F; van der Flier WM; Prins ND
Neurobiol Aging; 2014 Dec; 35(12):2665-2670. PubMed ID: 25018106
[TBL] [Abstract][Full Text] [Related]
15. [Measurements of cerebral blood flow and metabolism in patients with Alzheimer's disease].
Kitamura S; Terashi A
Rinsho Byori; 1990 May; 38(5):494-8. PubMed ID: 2381074
[TBL] [Abstract][Full Text] [Related]
16. Paradoxical hippocampus perfusion in mild-to-moderate Alzheimer's disease.
Ishii K; Sasaki M; Yamaji S; Sakamoto S; Kitagaki H; Mori E
J Nucl Med; 1998 Feb; 39(2):293-8. PubMed ID: 9476938
[TBL] [Abstract][Full Text] [Related]
17. Changes of migraine-related white matter hyperintensities after 3 years: a longitudinal MRI study.
Erdélyi-Bótor S; Aradi M; Kamson DO; Kovács N; Perlaki G; Orsi G; Nagy SA; Schwarcz A; Dóczi T; Komoly S; Deli G; Trauninger A; Pfund Z
Headache; 2015 Jan; 55(1):55-70. PubMed ID: 25319529
[TBL] [Abstract][Full Text] [Related]
18. Cognitive consequences of subcortical magnetic resonance imaging changes in Alzheimer's disease: comparison to small vessel ischemic vascular dementia.
Doddy RS; Massman PJ; Mawad M; Nance M
Neuropsychiatry Neuropsychol Behav Neurol; 1998 Oct; 11(4):191-9. PubMed ID: 9845410
[TBL] [Abstract][Full Text] [Related]
19. Can PET data differentiate Alzheimer's disease from vascular dementia?
Nagata K; Maruya H; Yuya H; Terashi H; Mito Y; Kato H; Sato M; Satoh Y; Watahiki Y; Hirata Y; Yokoyama E; Hatazawa J
Ann N Y Acad Sci; 2000 Apr; 903():252-61. PubMed ID: 10818514
[TBL] [Abstract][Full Text] [Related]
20. Sildenafil Improves Vascular and Metabolic Function in Patients with Alzheimer's Disease.
Sheng M; Lu H; Liu P; Li Y; Ravi H; Peng SL; Diaz-Arrastia R; Devous MD; Womack KB
J Alzheimers Dis; 2017; 60(4):1351-1364. PubMed ID: 29036811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
